Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2 1

Status

Completed 20Unknown 6Terminated 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Tumor-Agnostic 1Plasma cell 1Endocrine 1Breast 1

Conditions

Pain 1Neoplasm, Residual 1Multiple Myeloma 1Dwarfism, Pituitary 1Disease Progression 1Breast Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Cyclophosphamide 390Carboplatin 344Gemcitabine 332pembrolizumab 329Cisplatin 328Paclitaxel 297Radiotherapy 296Docetaxel 286Bevacizumab 253Rituximab 234Capecitabine 223Nivolumab 220Dexamethasone 206Fluorouracil 190fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 153Irinotecan 148Leucovorin 144Etoposide 144Cytarabine 133Cetuximab 129Bortezomib 129fludarabine phosphate 128Lenalidomide 126Erlotinib Hydrochloride 120Filgrastim 119Temozolomide 113Radiosurgery 113

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Terminated × Calcium × Clear all
NCT00998738 2016-02-04

Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer

Mayo Clinic

Phase 3 Terminated
1 enrolled 1 chart
Breast

Breast Neoplasms, Pain

NCT00145704 2013-04-08

Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density

State University of New York - Upstate Medical University

Phase NA Terminated
6 enrolled 3 charts
Endocrine

Bone Diseases, Metabolic, Dwarfism, Pituitary

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Novartis

Phase 3 Terminated
143 enrolled 10 charts
Plasma cell

Multiple Myeloma, Disease Progression

NCT00172068 2009-12-23

MRD-1

Novartis

Phase 2 Terminated
96 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡